EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery

Xosé Pérez-Fernández, Arnau Ulsamer, María Cámara-Rosell, Fabrizio Sbraga, Enric Boza-Hernández, Enrique Moret-Ruíz, Erika Plata-Menchaca, Doménech Santiago-Bautista, Patricia Boronat-García, Víctor Gumucio-Sanguino, Judith Peñafiel-Muñoz, Mercedes Camacho-Pérez und 5 weitere

JAMA · 2024

DOI: 10.1001/jama.2024.20630 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, 2024. Verfasst von Xosé Pérez-Fernández und 16 weiteren Autor:innen. Beteiligte Einrichtung: Facultat de Medicina Campus de Bellvitge Universitat de Barcelona L'Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Acute Kidney Injury, Cardiac Surgical Procedures, Cardiopulmonary Bypass, Hemofiltration. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Cardiac surgery – associated acute kidney injury (CSA-AKI) remains a significant problem following cardiopulmonary bypass (CPB). Various strategies are proposed to attenuate CSA-AKI, including extracorporeal blood purification (EBP), but little is known about the effect of EBP through an acrylonitrile-sodium methallylsulfonate/polyethyleneimine membrane during CPB.

Objective

To determine whether the use of an EBP device in a nonemergent cardiac surgery population reduces CSA-AKI after CPB. Design, Setting, and Participants This double-blind, randomized clinical trial was conducted in 2 tertiary hospitals in Spain. Patients 18 years or older undergoing nonemergent cardiac surgery who were at high risk for CSA-AKI were enrolled from June 15, 2016, through November 5, 2021, with follow-up data through February 5, 2022. Of 1156 patients assessed, 343 patients were randomized (1:1) to either receive EBP or standard care.

Intervention

Nonselective EBP device connected to the CPB circuit. Main Outcomes and Measures The primary outcome was the rate of CSA-AKI in the 7 days after randomization.

Results

Among 343 patients randomized (169 to receive EBP and 174 to receive usual care), the mean (SD) age was 69 (9) years and 119 were females. The rate of CSA-AKI was 28.4% (95% CI, 21.7%-35.8%) in the EBP group vs 39.7% (95% CI, 32.3%-47.3%) in the standard care group ( P = .03), with an adjusted difference of 10.4% (95% CI, 2.3%-18.5%) using a log-binomial model ( P = .01). No significant differences ( P > .05) were observed in most of the predefined clinical secondary end points or post hoc exploratory end points. In a sensitivity analysis, EBP was found to be more effective in terms of CSA-AKI reduction in patients with chronic kidney disease, diabetes, hypertension, low left ventricular ejection fraction (<40%), and lower body mass index (<30). No differences were observed between the groups in adverse events tracking. Conclusions and Relevance The use of a nonselective EBP device connected to the CPB circuit in a nonemergent population of patients undergoing cardiac surgery was associated with a significant reduction of CSA-AKI in the first 7 days after surgery. Trial Registration ClinicalTrials.gov Identifier: NCT02518087

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryCardiac Surgical ProceduresCardiopulmonary BypassHemofiltrationPostoperative ComplicationsAgedFemaleHumansMaleMiddle AgedAcrylonitrileDouble-Blind MethodMembranes, ArtificialIncidence

Substanzen

AcrylonitrileMembranes, Artificial

Autor:innen und Institutionen

  • Facultat de Medicina Campus de Bellvitge Universitat de Barcelona L'Hospitalet de Llobregat, Barcelona, Spain.
  • Institut de Investigació Biomédica de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain.
  • Hospital universitari de Bellvitge L'Hospitalet de LLobregat, Barcelona, Spain.
  • Hospital universitari Germans Trias i Pujol Badalona, Barcelona, Spain.
  • Hospital universitari Santa Creu i Sant Pau, Barcelona, Spain.
  • Royal Surrey NHS Foundation Trust & School of Medicine, University of Surrey, Guildford, United Kingdom.

Zitieren

APA

Pérez-Fernández, X., Ulsamer, A., Cámara-Rosell, M., Sbraga, F., Boza-Hernández, E., Moret-Ruíz, E., Plata-Menchaca, E., Santiago-Bautista, D., Boronat-García, P., Gumucio-Sanguino, V., Peñafiel-Muñoz, J., Camacho-Pérez, M., Betbesé-Roig, A., Forni, L., Campos-Gómez, A., Sabater-Riera, J., & SIRAKI02 Study Group (2024). Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery. JAMA. https://doi.org/10.1001/jama.2024.20630

Vancouver

Pérez-Fernández X, Ulsamer A, Cámara-Rosell M, Sbraga F, Boza-Hernández E, Moret-Ruíz E, et al. Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery. JAMA. 2024. doi:10.1001/jama.2024.20630

BibTeX
@article{PrezFernndez2024,
  author = {Pérez-Fernández, Xosé and Ulsamer, Arnau and Cámara-Rosell, María and Sbraga, Fabrizio and Boza-Hernández, Enric and Moret-Ruíz, Enrique and Plata-Menchaca, Erika and Santiago-Bautista, Doménech and Boronat-García, Patricia and Gumucio-Sanguino, Víctor and Peñafiel-Muñoz, Judith and Camacho-Pérez, Mercedes and Betbesé-Roig, Antoni and Forni, Lui and Campos-Gómez, Ana and Sabater-Riera, Joan and SIRAKI02 Study Group, SIRAKI02 Study Group},
  title = {Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.20630}
}
Kostenlos starten →